Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

被引：0
作者：
Chang, Sam S.
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [41] Re: EV-301 Long-term Outcomes: 24-month Findings from the Phase III Trial of Enfortumab Vedotin Versus Chemotherapy in Patients with Previously Treated Advanced Urothelial Carcinoma
    Drake, Marcus J.
    Birder, Lori A.
    [J]. EUROPEAN UROLOGY, 2024, 86 (02) : 183 - 184
  • [42] Analysis of hard-to-treat subgroups from EV-301: A phase III trial of enfortumab vedotin (EV) vs chemotherapy for previously treated advanced urothelial carcinoma
    Rosenberg, J. E.
    Powles, T.
    Sonpavde, G. P.
    Loriot, Y.
    Duran, I.
    Lee, J. L.
    Matsubara, N.
    Vulsteke, C.
    Castellano, D.
    Mamtani, R.
    Sridhar, S. S.
    Pappot, H.
    Gurney, H. P.
    Bedke, J.
    Van der Heijden, M. S.
    Campbell, M.
    Wu, C.
    Matsangou, M.
    Petrylak, D. P.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S710 - S711
  • [43] Enfortumab vedotin in the previously treated advanced head and neck cancer (HNC) cohort of EV-202
    Swiecicki, Paul
    Yilmaz, Emrullah
    Rosenberg, Ari J.
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Wang, Lu
    Gorla, Seema Rao
    Geiger, Jessica Lyn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Enfortumab Vedotin Nursing perspectives on the management of adverse events in patients with locally advanced or metastatic urothelial carcinoma
    Pace, Amanda
    Brower, Blaine
    Conway, Dawn
    Leis, Dayna
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (02) : E1 - E9
  • [45] Therapeutic efficacy and safety of biweekly administration of enfortumab vedotin for urothelial carcinoma
    Nakagawa, Ryunosuke
    Izumi, Kouji
    Toriumi, Ren
    Aoyama, Shuhei
    Kamijima, Taiki
    Kano, Hiroshi
    Makino, Tomoyuki
    Naito, Renato
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Kawaguchi, Shohei
    Shigehara, Kazuyoshi
    Nohara, Takahiro
    Mizokami, Atsushi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (12) : 1329 - 1335
  • [46] Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis
    Khosla, Harshit
    Bhatt, Sita
    Wang, Ming-Jin
    Gignac, Gretchen
    Mittal, Kriti
    Patel, Jasmine
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (05) : 941 - 944
  • [47] Harnessing potent therapies with care: enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma
    Ghatalia, Pooja
    Plimack, Elizabeth R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (12) : 818 - 819
  • [48] Outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma and histology variants: Analysis of the UNITE study.
    Jindy, Tanya
    Jiang, Cindy Y.
    Alhalabi, Omar
    Nguyen, Charles B.
    Nizam, Amanda
    Basu, Arnab
    Bilen, Mehmet Asim
    Zakharia, Yousef
    Milowsky, Matthew I.
    Brown, Jason R.
    Kilari, Deepak
    Emamekhoo, Hamid
    Hoimes, Christopher J.
    Khaki, Ali Raza
    Gupta, Shilpa
    Grivas, Petros
    Bellmunt, Joaquim
    Campbell, Matthew T.
    Alva, Ajjai Shivaram
    Koshkin, Vadim S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 652 - 652
  • [49] Biomarkers of treatment (Tx)-related toxicity in advanced urothelial carcinoma (aUC) pts treated with enfortumab vedotin (EV): Analysis of UNITE study
    Nizam, A.
    Zhang, L.
    Jindal, T.
    Nguyen, C. B.
    Alhalabi, O.
    Basu, A.
    Evans, S. P.
    Hoimes, C. J.
    Zakharia, Y.
    Milowsky, M. I.
    Kilari, D.
    Shah, S. A.
    Davis, N. B.
    Emamekhoo, H.
    Gupta, S.
    Bellmunt, J.
    Grivas, P.
    Campbell, M. T.
    Alva, A.
    Koshkin, V. S.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1219 - S1219
  • [50] Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
    Sayegh, Nicolas
    Jo, Yeonjung
    Gebrael, Georges
    Tripathi, Nishita
    Chigarira, Beverly
    Srivastava, Ayana
    Nordblad, Blake
    Dal, Emre
    Chehade, Chadi Hage
    Mahlow, Jon
    Maughan, Benjamin L.
    Gupta, Sumati
    Agarwal, Neeraj
    Swami, Umang
    [J]. CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
12345